Modeling and predicting therapeutic efficacy of cancer treatments
Dean Felsher - Professor of Medicine and of Pathology, Director of TRAM
Seed Grant Committee Member & Bio-X Affiliated Faculty
Dr. Felsher's laboratory investigates how oncogenes initiate and sustain tumorigenesis.
Stanford Bio-X Seed Grants
Interdisciplinary Initiatives Program Seed Grant: Imaging changes in immune surveillance by natural killer (NK) cells during the progression of MYC oncogene-driven lymphomas
Interdisciplinary Initiatives Program Round 9 - 2018
In Vivo Metabolic Imaging of Senescent Cells Using Hyperpolarized 13C MRS
Interdisciplinary Initiatives Program Round 7 - 2014
Other Stanford Bio-X Supported Research
Prediction of Therapeutic Efficacy of Targeted Oncogene Inactivation via PET Imaging using a Novel Smart Apoptosis Probe ([18F]CAIP)
Supported BioSTAR Sponsored Research Project - 2012
Research News
Liver cancer stem cells shown to use immune system as shield to spark disease recurrence
October 9, 2024 - Stanford Medicine News Center
A Stanford Medicine-led study from Stanford Bio-X faculty members Dean Felsher, James Zou, Nishita...
Protein increases signals that protect cancer cells
March 10, 2016 - Stanford Medicine News Center
Researchers under Bio-X affiliates Dean Felsher and Irv Weissman, including 2014 USRP participant...
Blocking a metabolic pathway may shrink aggressive form of common kidney cancer
May 11, 2015 - Stanford Medicine News Center
Bio-X affiliated faculty members Dean Felsher and Richard Zare find that an aggressive kidney cancer...